Timeline

Danielle PEREZ BERCOFF

Deputy Director of National Reference Center

06 Oct 2023

publication

Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern.

19 Feb 2023

publication

Vaccine- and Breakthrough Infection-Elicited Pre-Omicron Immunity More Effectively Neutralizes Omicron BA.1, BA.2, BA.4 and BA.5 Than Pre-Omicron Infection Alone.

12 Jul 2022

publication

Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone.

26 Nov 2021

publication

TERT Promoter Mutations Increase Sense and Antisense Transcription from the TERT Promoter.

12 Apr 2021

publication

Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus.

19 Mar 2020

publication

The Solo Play of TERT Promoter Mutations.

01 Sep 2019

publication

Predominance of the heterozygous CCR5 delta-24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR5 addressing at the cell surface.

17 Feb 2018

publication

Reassessment of the capacity of the HIV-1 Env cytoplasmic domain to trigger NF-κB activation.

01 Jan 2016

publication

The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell Transmission.

16 Nov 2015

publication

Characteristics and spread to the native population of HIV-1 non-B subtypes in two European countries with high migration rate.

27 Jul 2015

nrc

Viruses of Respiratory Infections (including Influenza and SARS-CoV-2)

25 Feb 2015

publication

Reliable genotypic tropism tests for the major HIV-1 subtypes.

01 Jan 2015

publication

Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe.

01 Oct 2014

publication

COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification.

02 Sep 2014

publication

Closing the ring: a fourth extracellular loop in chemokine receptors.

24 May 2013

publication

The frantic play of the concealed HIV envelope cytoplasmic tail.

01 Jan 2013

publication

HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected].

01 May 2012

publication

Automated sequence analysis and editing software for HIV drug resistance testing.

01 Dec 2011

publication

Rescue of HIV-1 long-time archived X4 strains to escape maraviroc.

01 Aug 2011

publication

Modulation of TRIM5alpha activity in human cells by alternatively spliced TRIM5 isoforms.

01 Jan 2011

publication

Impact of the HIV-1 env genetic context outside HR1-HR2 on resistance to the fusion inhibitor enfuvirtide and viral infectivity in clinical isolates.

29 Nov 2010

publication

Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir.

01 Oct 2009

publication

Selective-advantage profile of human immunodeficiency virus type 1 integrase mutants explains in vivo evolution of raltegravir resistance genotypes.

01 May 2007

publication

Human immunodeficiency virus type 1: resistance to nucleoside analogues and replicative capacity in primary human macrophages.

01 Jul 2003

publication

CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam.

01 Jun 2003

publication

Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines.

01 Apr 2003

publication

Fcgamma receptor-mediated suppression of human immunodeficiency virus type 1 replication in primary human macrophages.

01 Dec 2002

publication

A little guide for advanced search:

Timeline

Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern.

Vaccine- and Breakthrough Infection-Elicited Pre-Omicron Immunity More Effectively Neutralizes Omicron BA.1, BA.2, BA.4 and BA.5 Than Pre-Omicron Infection Alone.

Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone.

TERT Promoter Mutations Increase Sense and Antisense Transcription from the TERT Promoter.

Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus.

The Solo Play of TERT Promoter Mutations.

Predominance of the heterozygous CCR5 delta-24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR5 addressing at the cell surface.

Reassessment of the capacity of the HIV-1 Env cytoplasmic domain to trigger NF-κB activation.

The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell Transmission.

Characteristics and spread to the native population of HIV-1 non-B subtypes in two European countries with high migration rate.

Viruses of Respiratory Infections (including Influenza and SARS-CoV-2)

Reliable genotypic tropism tests for the major HIV-1 subtypes.

Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe.

COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification.

Closing the ring: a fourth extracellular loop in chemokine receptors.

The frantic play of the concealed HIV envelope cytoplasmic tail.

HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected].

Automated sequence analysis and editing software for HIV drug resistance testing.

Rescue of HIV-1 long-time archived X4 strains to escape maraviroc.

Modulation of TRIM5alpha activity in human cells by alternatively spliced TRIM5 isoforms.

Impact of the HIV-1 env genetic context outside HR1-HR2 on resistance to the fusion inhibitor enfuvirtide and viral infectivity in clinical isolates.

Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir.

Selective-advantage profile of human immunodeficiency virus type 1 integrase mutants explains in vivo evolution of raltegravir resistance genotypes.

Human immunodeficiency virus type 1: resistance to nucleoside analogues and replicative capacity in primary human macrophages.

CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam.

Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines.

Fcgamma receptor-mediated suppression of human immunodeficiency virus type 1 replication in primary human macrophages.

Macrophage activation and HIV infection: can the Trojan horse turn into a fortress?